Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PsyBio Therapeutics Corp. Proxy Solicitation & Information Statement 2022

May 19, 2022

46634_rns_2022-05-19_d93e3318-b85d-4275-8f26-41a642a8d974.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

May 19, 2022

==> picture [203 x 46] intentionally omitted <==

Filed via SEDAR

To All Applicable Exchanges and Securities Regulatory Authorities

Subject: Psybio Therapeutics Corp. (the "Issuer") Notice of Meeting and Record Date - Amended

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

MeetingType: Annual and Special Meeting
MeetingDate: August 11,2022
Record Date for Notice of Meeting: June 13,2022
Record Date for Voting (if applicable): June 13,2022
Beneficial OwnershipDetermination Date: June 13,2022
Class of Securities Entitled to Vote: Multiple Voting SharesSubordinate VotingShares
ISIN: CA6936972034CA6936971044
Issuer sending proxymaterials directlyto NOBOs: No
Issuerpayingfor deliveryto OBOs: No
Notice and Access for Beneficial Holders: No
Notice and Access for Registered Holders: No

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

ODYSSEY TRUST COMPANY AS AGENT FOR Psybio Therapeutics Corp.